A new FDA Web site defines consumer print advertising so the general public can spot bad and good pharma ads. As a bonus, the site also serves as a checklist for pharma marketers trying not to step on any regulatory toes.

In an effort to give healthcare professionals and patients a one-stop source for factual drug safety information and treatment options, Pfizer has launched a handy new medicine safety Web site with a bevy of bells and whistles.

Celebrity spokesperson Dr. Jarvik has been replaced with a Regular Joe in the latest Lipitor DTC spots. Will the switch make a difference?

A new study finds that doctors are three times more likely to prescribe generics when they don’t have access to free samples of branded drugs.

As oncology grows, its advertising is growing up—leaving behind the mechanistic images and scientific themes of past campaigns

How will pharma fare in the new age of health and wellness marketing?

The smart way to CRM is through SaaS

A new study tracks six high-traffic drugs that are turning up on shady online pharmacies, usually at huge discounts. The conclusion: Fancy Web sites are suckering customers and costing pharma money and credibility.

Digitas Health touts an increase in physician traffic to AstraZeneca's pain med site. The driver? An innovative piece of mail sporting a USB Web key to access product information.